BACE2 and melanoma: A similar behavior was also observed when BACE2 was genetically knocked down excluding off‐target effects of the drug and demonstrating that the impairment of BACE2 expression directly impacts on cell proliferation in metastatic melanoma cells (Fig EV5C).